RxDoctor Payments Data

Diana Bitner

Obstetrics & Gynecology · Grand Rapids, MINPI 1457308488

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (50.5%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Therapeuticsmd, Inc. at 55.5% of the total. Reporting peaked in 2019 at $29,653 and has fallen 67.6% since, to $9,614 in 2025. Among obstetrics & gynecology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$57,577in general payments, 2019–2025

Across 119 payments — averaging $483.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Therapeuticsmd, Inc.$32K
  • Bayer$23K
  • Astellas Pharma US Inc$716
  • Lupin Inc.$600
  • Cosette Pharmaceuticals Inc.$193
  • Novo Nordisk$191
  • plus $736 from 12 others

What the payments were for

  • Consulting fees$20,23635%
  • Speaking & faculty fees$29,09951%
  • Travel & lodging$4,5888%
  • Food & beverage$3,3716%
  • Education$2830%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$57,577 in reported general payments places this provider in the 95th percentile of 1,474 obstetrics & gynecology providers in Michigan.

See all obstetrics & gynecology providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
ImvexxyEstradiol18$8,391
Estradiol (Twice Weekly)Estradiol51$4,184
DottiEstradiol13$2,199
Estradiol27$2,127
ProgesteroneProgesterone, Micronized21$1,191
Clobetasol Propionate15$274
Escitalopram Oxalate14$70

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Therapeuticsmd, Inc.Imvexxy$31,948$8,39118 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,474 obstetrics & gynecology providers in Michigan.

Other obstetrics & gynecology in Grand Rapids

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →